Fenelzin
Изглед
Klinički podaci | |
---|---|
Prodajno ime | Beta-phenylethylhydrazine, Fenelzina [INN-Spanish], Fenelzyna, Fenelzyne |
Drugs.com | Monografija |
Način primene | Oralno |
Farmakokinetičkipodaci | |
Poluvreme eliminacije | 1,2-11,6 h |
Identifikatori | |
CAS broj | 51-71-8 |
ATC kod | N06AF03(WHO) |
PubChem | CID3675 |
DrugBank | DB00780 |
ChemSpider | 3547 |
KEGG | C07430 |
ChEMBL | CHEMBL1089 |
Hemijski podaci | |
Formula | C8H12N2 |
Molarna masa | 136,194 |
| |
| |
Fizički podaci | |
Tačka ključanja | 74 °C (165 °F) |
Fenelzinjeorgansko jedinjenje,koje sadrži 8atomaugljenikai imamolekulsku masuod 136,194Da.[1][2][3][4]
Osobine
[уреди|уреди извор]Osobina | Vrednost |
---|---|
Broj akceptora vodonika | 2 |
Broj donora vodonika | 2 |
Broj rotacionih veza | 3 |
Particioni koeficijent[5](ALogP) | 0,9 |
Rastvorljivost[6](logS,log(mol/L)) | -1,9 |
Polarna površina[7](PSA,Å2) | 38,0 |
Reference
[уреди|уреди извор]- ^Nolen WA: [Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression] Ned Tijdschr Geneeskd. 2003 Oct 4;147(40):1940-3.PMID14574774
- ^Sowa BN, Holt A, Todd KG, Baker GB: Monoamine oxidase inhibitors, their structural analogues, and neuroprotection. Indian J Exp Biol. 2004 Sep;42(9):851-7.PMID15462176
- ^Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011).„DrugBank 3.0: a comprehensive resource for omics research on drugs”.Nucleic Acids Res.39(Database issue): D1035—41.PMC3013709 .PMID21059682.doi:10.1093/nar/gkq1126.
- ^David S. Wishart; Craig Knox; An Chi Guo; Dean Cheng; Savita Shrivastava; Dan Tzur; Bijaya Gautam; Murtaza Hassanali (2008).„DrugBank: a knowledgebase for drugs, drug actions and drug targets”.Nucleic acids research.36(Database issue): D901—6.PMC2238889 .PMID18048412.doi:10.1093/nar/gkm958.
- ^Ghose, A.K.; Viswanadhan V.N. & Wendoloski, J.J. (1998).„Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”.J. Phys. Chem. A.102:3762—3772.doi:10.1021/jp980230o.
- ^Tetko IV, Tanchuk VY, Kasheva TN, Villa AE (2001).„Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”.Chem Inf. Comput. Sci.41:1488—1493.PMID11749573.doi:10.1021/ci000392t.
- ^Ertl P.; Rohde B.; Selzer P. (2000).„Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”.J. Med. Chem.43:3714—3717.PMID11020286.doi:10.1021/jm000942e.
Literatura
[уреди|уреди извор]- Hardman JG, Limbird LE, Gilman AG (2001).Goodman & Gilman's The Pharmacological Basis of Therapeutics(10. изд.). New York: McGraw-Hill.ISBN0071354697.doi:10.1036/0071422803.
- Thomas L. Lemke; David A. Williams, ур. (2007).Foye's Principles of Medicinal Chemistry(6. изд.). Baltimore: Lippincott Willams & Wilkins.ISBN0781768799.
Spoljašnje veze
[уреди|уреди извор]
Molimo Vas, obratite pažnju navažno upozorenje u vezi sa temama izoblasti medicine (zdravlja). |